Centrum 7/6  banner

Issues

Desperate times cue drug middlemen’s loathsome measures

Desperate times cue drug middlemen’s loathsome measures

Estimates project that prescription drug middlemen – pharmacy benefit managers (PBMs) – more than doubled their revenue over the course of the last decade and will do so again in the current decade. For example, Fortune Business Insights projects PBM revenues of more than $800 billion by 2030, and Grand View Research projects more than

DIR reform in 2024: One step forward, two steps back

DIR reform in 2024: One step forward, two steps back

Direct and indirect remuneration was initiated with best intentions. DIR was originally introduced to create a pharmacy reimbursement model wherein payers would reimburse pharmacies based on patient outcomes, a pay-for-performance model. It included adherence measures and the use of generic drugs so that pharmacies would focus on better outcomes and lower costs — otherwise known

Emerson team is optimizing retailers’ digital efforts

Emerson team is optimizing retailers’ digital efforts

BONITA SPRINGS, Fla. — The emerging leaders of the Emerson Group are bringing their digital commerce expertise to retailers. The team was selected by founder and president Scott Emerson, and the members have honed their e-commerce skills with CPG brands. Now they want to enable retailers — like the ones they spoke to at the

First Quality continues to invest in clinical support

First Quality continues to invest in clinical support

GREAT NECK, N.Y. — With more consumers turning to retail pharmacies as a resource for their health care needs, First Quality continues to invest in its clinical support services to provide education and support on incontinence, menstrual care and baby care. The clinical support reflects First Quality’s heritage in the health care industry, which began

Listerine Clinical Solutions addresses variety of concerns

Listerine Clinical Solutions addresses variety of concerns

SKILLMAN, N.J. — Last fall, Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced a major extension to its Listerine line with Listerine Clinical Solutions. The new lineup includes: Listerine Clinical Solutions Antiseptic Gum Health Mouthwash, Clinical Solutions Breath Defense Mouthwash and Clinical Solutions Teeth Strength – Mouthwash. “As the No. 1

Firework’s Cladek discusses digital store enhancements

Firework’s Cladek discusses digital store enhancements

NEW YORK — The Agile Innovation Series focuses on the need for organizations to constantly evolve and innovate with an agile mind-set to remain viable in today’s dynamic world. Throughout the series accelerate360’s Trey Holder explores the current business environment through interviews with leaders in a variety of fields. This month, Holder caught up with

Hallmark, Venmo continue to transform gift-giving

Hallmark, Venmo continue to transform gift-giving

KANSAS CITY — In 2024, Hallmark will continue to build on the popularity of Hallmark + Venmo Cards. These new cards offer a unique and convenient way of gifting to friends and family. “With this recently launched, first-of-its kind collaboration, customers can now securely send money with Venmo in a physical Hallmark card. By bringing

Proffitt on Dr. Reddy’s private label O-T-C business

Proffitt on Dr. Reddy’s private label O-T-C business

Lindsay Proffitt, who runs the private label over-the-counter drug business at Dr. Reddy’s, spoke with Chain Drug Review about her role, the significance of store brands for the company and the opportunities they present. CDR: What is your title and what are your responsibilities? PROFFITT: My title is head of private label O-T-C product management,

Staying consumer-centric in a digital world

Staying consumer-centric in a digital world

“The future is purchased by the present,” wrote Samuel Johnson in one of his essays for The Rambler. That idea was reflected during a panel discussion at last month’s FMI Midwinter Conference. Members of the group — which included David Best, president and chief operating officer of Coborn’s Inc.; Sandy Douglas, chief executive officer of

Key challenges in chemicals and materials R&D

Key challenges in chemicals and materials R&D

The chemical and materials industry contributes roughly $5.7 trillion to global GDP (gross domestic product) and supports an estimated 120 million jobs, according to a recent report published by the International Council of Chemical Associations. To meet massive demand, chemicals and materials research and development teams face many challenges, including the need to move at

1 2 3 270
PP_1170x120_10-25-21